SCHEMBL5255371

SCHEMBL5255371

CCCCCn1c(=O)ccc2c(-c3ccccc3Cl)nc(S(C)(=O)=O)nc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.44
TLR8 Q9NR97 1/20 0.39
CCNB2 O95067 1/20 0.39
CCNE2 O96020 1/20 0.39
CDK1 P06493 1/20 0.39
FGFR1 P11362 1/20 0.39
CDK4 P11802 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
FGFR2 P21802 1/20 0.39
FGFR4 P22455 1/20 0.39
FGFR3 P22607 1/20 0.39
CCND1 P24385 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CCND2 P30279 1/20 0.39
CCND3 P30281 1/20 0.39
CCNA1 P78396 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
EPHB4 P54760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5258365 0.88 TLR8 (0.39) TLR8CCNB2CCNE2CDK1FGFR1
SCHEMBL5253286 0.83 MAPK14 (0.42) MAPK14TLR8CCNB2CCNE2CDK1
SCHEMBL1062919 0.80 MAPK14 (0.42) MAPK14HSD11B1MAPK13MAPK12MAPK11
SCHEMBL2944615 0.79 SIK1 (0.43) MAPK14TLR8CCNB2CCNE2CDK1
SCHEMBL2941239 0.79 FGFR1 (0.42) MAPK14TLR8CCNB2CCNE2CDK1
SCHEMBL1726714 0.79 CDK1 (0.41) MAPK14TLR8CCNB2CCNE2CDK1
SCHEMBL1065189 0.78 MAPK14 (0.44) MAPK14HSD11B1MAPK13MAPK12MAPK11
SCHEMBL2945023 0.77 FGFR2 (0.42) CCNB2CCNE2CDK1FGFR1CDK4
SCHEMBL2945196 0.76 MAPK14 (0.42) MAPK14TLR8CCNB2CCNE2CDK1
SCHEMBL5253164 0.76 TDP1 (0.41) CCNB2CCNE2CDK1FGFR1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1333833-A4 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-10-24 EP disclosed
EP-1333833-A2 NOVEL COMPOUNDS SmithKline Beecham Corporation (US) 2003-08-13 EP disclosed
WO-2002059083-A2 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2002-08-01 WO disclosed